Visibility and Analytics Network (VAN) approach to improve immunization supply chain and management performance system in Pakistan

Abstract

Background Pakistan has been experiencing several immunization related challenges. The supply chain management information system (MIS) is considered an important component of immunization services as it can improve visibility in key areas such as vaccine shortages or wastage. This study assessed the effectiveness of the Visibility and Analytics Network (VAN) approach in improving vaccine supply and availability of stocks by comparing the situation in intervention and non-intervention districts in Sindh province of Pakistan. Methods We utilized a quantitative and qualitative approach to collect data to assess the VAN approach in two districts of Sindh province in Pakistan. The data were collected between August and October 2017. VAN is a systematic monitoring system which measures the performance of vaccine supply chain management based on a set of indicators. We assessed storage facilities of the Expanded Programme on Immunization (EPI) in Sindh and interviewed personnel involved using a pre-tested data collection tool. We also conducted in depth interviews with senior management to assess performance of VAN, adoption mechanism and needs to scale up the VAN approach. Results We assessed 52 EPI facilities of Sindh province government. In the intervention district 83.3% managers were using MIS data for decision making related to vaccine supplies whereas in the non- intervention district no MIS based data were available. Ninety percent of stores were maintaining a stock registry and 100% supplies matched with requisitions in the intervention district compared to 40% and 35% in the non-intervention district for the same variables. Vaccine wastage was high in the non- intervention district (BCG 46.7% vs 33.9; OPV 13.5% vs 9.5%; pneumococcal 11.4% vs 7.4%). In-depth interview findings suggested that the VAN approach provided data guided monitoring in Pakistan for the first time. The approach also enabled district managers to make timely decisions. Conclusion The VAN approach improves vaccine supply chain management. It should be scaled up and implemented at national or sub national especially in countries struggling with vaccine supply chain management.

COVID-19 vaccine wastage and distribution disparities in Pakistan: an editorial

“…Local or nearby vaccine manufacturing has positively contributed to increasing vaccine availability and access. Local government and pharmaceutical manufacturers can put their efforts into prioritizing knowledge transfer, improving supply chain factors, and removing other potential barriers resulting in inequitable distribution and vaccine wastage 7 , 8 .…”

Trends in and Correlates of Short-Acting Contraceptive Stock-Outs: Multicountry Analysis of Performance Monitoring for Action Agile Platform Data

“… 14 Despite the global emphasis on addressing stock-outs, many countries still lack data, and few countries routinely monitor facility-level stock-outs. 15 , 16 The Service Provision Assessment (SPA) 17 and the Service Availability and Readiness Assessment (SARA) surveys 18 are standardized health facility assessment tools that are widely used to collect information on service availability and quality-of-care measures for a variety of health services, including FP. SARA surveys are typically conducted approximately every 5 years, whereas SPA surveys are implemented less frequently.…”

Perceptions of and Practical Experience with the National Surveillance Centre in Managing Medicines Availability Amongst Users within Public Healthcare Facilities in South Africa: Findings and Implications

“…The goal of the Visibility and Analytics Network (VAN) operating model is to provide end-to-end visibility of the supply chain. It is a set of supply chain capabilities with a shared service at a central point, built on people, policies, processes, and technology [ 16 , 17 , 18 , 19 , 20 ]. In South Africa, several innovations have recently been developed and implemented to improve medicines availability and access in the public system.…”